MRTX   $58.625  -0.15% Market Closed

Mirati Therapeutics Inc
Total Cash 978.52M
totalCashPerShare 13.949
EBITDA -760.68M
Total Debt 50.22M
quickRatio 7.254
currentRatio 7.542
Total Revenue 38.19M
debtToEquity 5.306
Revenue/Share 0.639
ROA -0.393
ROE -0.69947
grossProfits
freeCashflow -313.81M
operatingCashflow -594.09M
earningsGrowth
revenueGrowth 2.02
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -10.4911
profitMargins 0.0
enterpriseValue 3.19B
forwardPE -7.0131426
floatShares 38.91M
sharesOutstanding 70.15M
sharesShort 4.39M
sharesShortPriorMonth 4.74M
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.02%
heldPercentInstitutions 1.18%
Short Ratio help_outline 2.88%
shortPercentOfFloat 0.08%
impliedSharesOutstanding
bookValue 13.499
Price To Book help_outline 4.35
earningsQuarterlyGrowth
netIncomeToCommon -725.88M
trailingEps -12.18%
forwardEps -8.37%
enterpriseToEbitda -4.19
lastDividendValue
lastDividendDate
currentQuarterEstimate -2.43 4Q 2023
institutionsCount 309
lastUpdated March 16, 2024, 10:22 a.m.